GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (NAS:COO) » Definitions » PS Ratio

COO (The Cooper) PS Ratio : 4.88 (As of Dec. 14, 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, The Cooper's share price is $94.85. The Cooper's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 was $19.43. Hence, The Cooper's PS Ratio for today is 4.88.

The historical rank and industry rank for The Cooper's PS Ratio or its related term are showing as below:

COO' s PS Ratio Range Over the Past 10 Years
Min: 3.34   Med: 5.25   Max: 8.28
Current: 4.93

During the past 13 years, The Cooper's highest PS Ratio was 8.28. The lowest was 3.34. And the median was 5.25.

COO's PS Ratio is ranked worse than
64.72% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 3.29 vs COO: 4.93

The Cooper's Revenue per Sharefor the three months ended in Oct. 2024 was $5.07. Its Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 was $19.43.

Good Sign:

The Cooper Companies Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of The Cooper was 7.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.30% per year.

During the past 13 years, The Cooper's highest 3-Year average Revenue per Share Growth Rate was 30.80% per year. The lowest was -62.60% per year. And the median was 8.40% per year.

Back to Basics: PS Ratio


The Cooper PS Ratio Historical Data

The historical data trend for The Cooper's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper PS Ratio Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.51 7.10 4.11 4.32 5.39

The Cooper Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.32 5.08 4.77 4.91 5.39

Competitive Comparison of The Cooper's PS Ratio

For the Medical Instruments & Supplies subindustry, The Cooper's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's PS Ratio distribution charts can be found below:

* The bar in red indicates where The Cooper's PS Ratio falls into.



The Cooper PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

The Cooper's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=94.85/19.434
=4.88

The Cooper's Share Price of today is $94.85.
The Cooper's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $19.43.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


The Cooper  (NAS:COO) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


The Cooper PS Ratio Related Terms

Thank you for viewing the detailed overview of The Cooper's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper Business Description

Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Executives
White Albert G Iii officer: VP & Treasurer 6790, SPRINGDALE COURT, VICTOR NY 14564
Agostino Ricupati officer: Sr. VP, Finance & Tax C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Brian G Andrews officer: Treasurer 4300A 17TH STREET, SAN FRANCISCO CA 94114
Daniel G Mcbride officer: VP and Senior Counsel 5 EL CORTE, ORINDA CA 94563
Robert S Weiss director, officer: EVP and CFO 6140 STANERIDGE MALL RES #590, PLEASSANTON CA 94503
Gary S Petersmeyer director 3400 CENTRAL AVENUE, SANTA CLARA CA 95051
Warner Gerard H Iii officer: President, CooperVision, Inc. C/O COOPER COMPANIES INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583
Jody S Lindell director 2536 FILLMORE ST., SAN FRANCISCO CA 94115
Cynthia L Lucchese director 7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260
Nicholas Khadder officer: VP, General Counsel & Corp Sec 2836 JOHNSON AVENUE, ALAMEDA CA 94501
Maria Rivas director C/O MEDIDATA SOLUTIONS, INC., 350 HUDSON STREET, 9TH FLOOR, NEW YORK NY 10014
Teresa S Madden director 414 NICOLLET MALL, MINNEAPOLIS MN 55401
Robert D Auerbach officer: President, CSI C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588
Holly R Sheffield officer: EVP, CSO C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Mark J Drury officer: VP, General Counsel & Sec. C/O COOPERCOMPANIES, 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583